Mancera, Maria Elaine .
HRN: 24-70-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2025
CEFTRIAXONE 1G (VIAL)
01/30/2025
02/06/2025
IV
2 G
OD
S/p NSD WITH REPAIR
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes